Published in J Virol on November 01, 1988
Expression of rotavirus VP2 produces empty corelike particles. J Virol (1991) 2.38
Bluetongue virus: dissection of the polymerase complex. J Gen Virol (2008) 1.17
Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol (1992) 1.14
Expression of largest RNA segment and synthesis of VP1 protein of bluetongue virus in insect cells by recombinant baculovirus: association of VP1 protein with RNA polymerase activity. Nucleic Acids Res (1989) 1.13
Identification of bluetongue virus VP6 protein as a nucleic acid-binding protein and the localization of VP6 in virus-infected vertebrate cells. J Virol (1990) 1.11
Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res (1993) 1.08
Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress. Virol J (2007) 1.08
Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release. J Virol (2004) 1.06
Recombinant virus vaccine for bluetongue disease in sheep. J Virol (1990) 1.02
Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells. J Clin Microbiol (1993) 0.99
Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis. Virol J (2012) 0.98
Minimum requirements for bluetongue virus primary replication in vivo. J Virol (2012) 0.94
Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers. J Virol (1998) 0.89
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J Virol (2005) 0.88
An indirect double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) using baculovirus-expressed antigen for the detection of antibodies to glycoprotein E of pseudorabies virus and comparison of the method with blocking ELISAs. Clin Diagn Lab Immunol (1996) 0.81
Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectives. ISRN Microbiol (2012) 0.78
Oncolytic bluetongue viruses: promise, progress, and perspectives. Front Microbiol (2011) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods (1984) 11.70
Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol (1987) 6.41
Structure of the bluetongue virus capsid. J Virol (1972) 3.27
Characterization of bluetongue virus ribonucleic acid. J Virol (1970) 2.45
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
Characterization of the tubules associated with the replication of three different orbiviruses. Virology (1979) 1.65
Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10. Nucleic Acids Res (1987) 1.59
The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus. Protein Eng (1989) 1.38
Protein synthesis in bluetongue virus-infected cells. Virology (1979) 1.34
Baculovirus expression of the small genome segment of Hantaan virus and potential use of the expressed nucleocapsid protein as a diagnostic antigen. J Gen Virol (1988) 1.21
Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology (1987) 1.18
A comparison of different cloned bluetongue virus genome segments as probes for the detection of virus-specified RNA. Virology (1987) 1.10
Electron microscopic study of the formation of bluetongue virus. Onderstepoort J Vet Res (1968) 0.94
Localization of the nonstructural protein NS1 in bluetongue virus-infected cells and its presence in virus particles. Virology (1988) 0.90
Visualization of the extracapsid coat in certain bluetongue-type viruses. Onderstepoort J Vet Res (1972) 0.82
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase. J Virol (1972) 3.84
Properties of the product synthesized by vesicular stomatitis virus particles. J Mol Biol (1971) 3.55
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol (2001) 2.96
Kinetics of RNA synthesis by vesicular stomatitis virus particles. J Mol Biol (1971) 2.86
Genome homology of vesicular stomatitis virus and defective T particles and evidence for the sequential transcription of the virion ribonucleic acid. J Virol (1972) 2.70
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Abdominal tuberculosis. Diagnosis by fine needle aspiration cytology. Acta Cytol (1993) 2.26
Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region. J Mol Biol (1981) 2.18
Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies. J Virol (1985) 2.17
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol (1990) 2.11
Initiation and direction of RNA transcription by vesicular stomatitis virus virion transcriptase. J Virol (1973) 1.95
Detection of homologous RNA sequences among six rhabdovirus genomes. J Virol (1974) 1.91
Isolation and properties of poliovirus minus strand ribonucleic acid. J Virol (1970) 1.88
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol (1990) 1.78
Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40. Proc Natl Acad Sci U S A (1981) 1.71
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
The crystal structure of bluetongue virus VP7. Nature (1995) 1.61
Behaviour of Chrysomya megacephala (Fabr.) and Hemipyrellia ligurriens (Wied.) as parasites of living animals under experimental conditions. S Afr J Med Sci (1971) 1.59
Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10. Nucleic Acids Res (1987) 1.59
Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases. Mycoses (2012) 1.48
Nucleoside triphosphate phosphotransferase. A new enzyme activity of oncogenic and non-oncogenic "budding" viruses. Biochim Biophys Acta (1971) 1.47
Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol (1990) 1.46
Spectrum of echocardiographic findings in bacterial endocarditis. Circulation (1976) 1.44
Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer (1999) 1.44
Molecular basis of bluetongue virus neutralization. J Virol (1983) 1.41
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology (1993) 1.39
Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. Int J Clin Pract (2013) 1.39
Transiently decreased sialylation of thyrotropin (TSH) in a patient with the euthyroid sick syndrome. Thyroid (1997) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
Complete nucleotide sequence of the group-reactive antigen VP7 gene of bluetongue virus. Nucleic Acids Res (1988) 1.37
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36
Three-dimensional structure of single-shelled bluetongue virus. J Virol (1992) 1.35
Nucleotide sequence of a cDNA clone of RNA segment 10 of bluetongue virus (serotype 10). J Gen Virol (1986) 1.34
Cloning of the bluetongue virus L3 gene. J Virol (1984) 1.33
Transcription of the influenza ribonucleic acid genome by a virion polymerase. 3. Completeness of the transcription process. J Virol (1972) 1.33
Signatures of the hydrogen bonding in the infrared bands of water. J Chem Phys (2005) 1.30
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol (1999) 1.29
Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins. Virology (1991) 1.29
Structure of bluetongue virus particles by cryoelectron microscopy. J Struct Biol (1993) 1.29
Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy. Virology (1992) 1.26
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem (1998) 1.26
Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol (2000) 1.24
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J Gen Virol (1990) 1.24
Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates. J Virol (1997) 1.24
A soxA gene, encoding a diheme cytochrome c, and a sox locus, essential for sulfur oxidation in a new sulfur lithotrophic bacterium. J Bacteriol (2000) 1.22
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy. Structure (1997) 1.21
Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol (2004) 1.20
Temporally distinct accumulation of transcripts encoding enzymes of the prechorismate pathway in elicitor-treated, cultured tomato cells. Proc Natl Acad Sci U S A (1995) 1.19
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol (2001) 1.19
Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology (1987) 1.18
The expressed VP4 protein of bluetongue virus binds GTP and is the candidate guanylyl transferase of the virus. Virology (1992) 1.18
Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol (1993) 1.17
[Microscopic hematuria in adults. Prevalence and associated factors]. Presse Med (1991) 1.17
The complete sequence of bluetongue virus serotype 10 segment 3 and its predicted VP3 polypeptide compared with those of BTV serotype 17. Virus Res (1985) 1.16
Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. Br Med J (1975) 1.16
High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Virus Res (1990) 1.15
Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol (1992) 1.14
Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance images. Neuroimage (2004) 1.14
Capping and methylation of mRNA by purified recombinant VP4 protein of bluetongue virus. Proc Natl Acad Sci U S A (1998) 1.14
Expression of bluetongue virus group-specific antigen VP3 in insect cells by a baculovirus vector: its use for the detection of bluetongue virus antibodies. J Gen Virol (1987) 1.13
Expression of largest RNA segment and synthesis of VP1 protein of bluetongue virus in insect cells by recombinant baculovirus: association of VP1 protein with RNA polymerase activity. Nucleic Acids Res (1989) 1.13
Analysis of the genomes of bluetongue viruses recovered from different states of the United States and at different times. Am J Epidemiol (1982) 1.13
Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology (2004) 1.13
Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract. J Clin Microbiol (2012) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aorta. Can Med Assoc J (1975) 1.12
Nucleotide sequence of cDNA clones encoding the outer capsid protein, VP5, of bluetongue virus serotype 10. J Gen Virol (1986) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Variation in the bluetongue virus neutralization protein VP2. J Gen Virol (1987) 1.11
Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res (1986) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Bluetongue virus core protein VP4 has nucleoside triphosphate phosphohydrolase activity. J Gen Virol (1998) 1.09
Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus. J Gen Virol (1990) 1.08
Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res (1993) 1.08
The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study. Psychopharmacology (Berl) (1997) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Guanylyltransferase and RNA 5'-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus. J Mol Biol (1998) 1.07
Antifungal susceptibility pattern of non-albicans Candida species & distribution of species isolated from Candidaemia cases over a 5 year period. Indian J Med Res (1996) 1.07
Homologous terminal sequences of the genome double-stranded RNAs of bluetongue virus. J Virol (1983) 1.07
Primary renal artery dissection. Presentation of two cases and brief review of the literature. Am J Nephrol (1987) 1.07
Popliteal venous aneurysm: a source of pulmonary embolism. AJR Am J Roentgenol (1981) 1.06
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. J Virol (2001) 1.06
Completion of the sequence of bluetongue virus serotype 10 by the characterization of a structural protein, VP6, and a non-structural protein, NS2. J Gen Virol (1989) 1.06
Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7. J Virol (1996) 1.06
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Membrane organization of bluetongue virus nonstructural glycoprotein NS3. J Virol (1998) 1.05
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Tumour inhibitory activity of chicory root extract against Ehrlich ascites carcinoma in mice. Fitoterapia (2002) 1.03
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J (1996) 1.01
Complementation of human immunodeficiency virus (HIV-1) gag particle formation. Virology (1994) 1.01
Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly. J Virol (2000) 1.01